- Home
- KSCP vs BCAB Comparison
KSCP vs BCAB Comparison
Compare KSCP & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- BCAB
- Stock Information
- Founded
- KSCP 2013
- BCAB 2007
- Country
- KSCP United States
- BCAB United States
- Employees
- KSCP N/A
- BCAB N/A
- Industry
- KSCP Telecommunications Equipment
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- KSCP Telecommunications
- BCAB Health Care
- Exchange
- KSCP Nasdaq
- BCAB Nasdaq
- Market Cap
- KSCP 29.3M
- BCAB 27.0M
- IPO Year
- KSCP 2022
- BCAB 2020
- Fundamental
- Price
- KSCP $5.77
- BCAB $0.42
- Analyst Decision
- KSCP Strong Buy
- BCAB Buy
- Analyst Count
- KSCP 3
- BCAB 2
- Target Price
- KSCP $17.00
- BCAB $1.00
- AVG Volume (30 Days)
- KSCP 390.6K
- BCAB 547.1K
- Earning Date
- KSCP 05-23-2025
- BCAB 05-06-2025
- Dividend Yield
- KSCP N/A
- BCAB N/A
- EPS Growth
- KSCP N/A
- BCAB N/A
- EPS
- KSCP N/A
- BCAB N/A
- Revenue
- KSCP $10,805,000.00
- BCAB $11,000,000.00
- Revenue This Year
- KSCP $19.31
- BCAB N/A
- Revenue Next Year
- KSCP $37.58
- BCAB N/A
- P/E Ratio
- KSCP N/A
- BCAB N/A
- Revenue Growth
- KSCP N/A
- BCAB N/A
- 52 Week Low
- KSCP $2.45
- BCAB $0.24
- 52 Week High
- KSCP $28.57
- BCAB $3.53
- Technical
- Relative Strength Index (RSI)
- KSCP 59.08
- BCAB 52.09
- Support Level
- KSCP $4.65
- BCAB $0.40
- Resistance Level
- KSCP $5.60
- BCAB $0.49
- Average True Range (ATR)
- KSCP 0.45
- BCAB 0.06
- MACD
- KSCP 0.06
- BCAB -0.01
- Stochastic Oscillator
- KSCP 85.17
- BCAB 20.00
About KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.